Amsteram And Irvine

AMSTERAM and IRVINE, California, June 1, 2011 - Agendia, a commercial-stage molecular cancer diagnostics company, announces today that it will present results from four completed and one ongoing study, at the Annual Meeting of the American Society of Clinical Oncology (ASCO).